{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:09:32Z","timestamp":1778573372526,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1417200"],"award-info":[{"award-number":["23ZR1417200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22171080"],"award-info":[{"award-number":["22171080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22471072"],"award-info":[{"award-number":["22471072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bmcl.2025.130265","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:10:03Z","timestamp":1746533403000},"page":"130265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and anti-GBM activities of amide-modified Curcumol derivatives"],"prefix":"10.1016","volume":"125-126","author":[{"given":"Shiqi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130265_bb0005","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1021\/acs.jmedchem.1c01946","article-title":"Glioblastoma: current status, emerging targets, and recent advances","volume":"65","author":"Thakur","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130265_bb0010","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous system cancers, version 3, 2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.bmcl.2025.130265_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-008-9538-0","article-title":"Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma in elderly patients","volume":"88","author":"Minniti","year":"2008","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.bmcl.2025.130265_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI89587","article-title":"Overcoming therapeutic resistance in glioblastoma: the way forward","volume":"127","author":"Osuka","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2025.130265_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13046-018-0916-y","article-title":"Enhanced efficacy of histone deacetylase inhibitor combined with Bromodomain inhibitor in glioblastoma","volume":"37","author":"Meng","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130265_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2018.10.013","article-title":"Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment","volume":"138","author":"Pinel","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmcl.2025.130265_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/neuonc\/nox142","article-title":"Divergent evolution of Temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with Radiosensitization","volume":"20","author":"Garnier","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bmcl.2025.130265_bb0040","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2004.11.019","article-title":"First-line chemotherapy with cisplatin plus fractionated Temozolomide in recurrent glioblastoma Multiforme: a phase II study of the Gruppo Italiano Cooperativo di neuro-Oncologia","volume":"22","author":"Brandes","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2025.130265_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1874467211205010102","article-title":"Temozolomide: mechanisms of action, repair and resistance","volume":"5","author":"Zhang","year":"2012","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130265_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","article-title":"Potential strategies overcoming the Temozolomide resistance for glioblastoma","volume":"58","author":"Jiapaer","year":"2018","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.bmcl.2025.130265_bb0055","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1158\/1538-7445.AM2018-5905","article-title":"Sp1 acetylation associates with Stemness characteristics in Temozolomide resistant glioblastoma","volume":"78","author":"Chuang","year":"2018","journal-title":"AACR Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130265_bb0060","first-page":"47","article-title":"Drug discovery and development with plant-derived compounds","volume":"65","author":"Potterat","year":"2008","journal-title":"Nat Compd Drugs"},{"key":"10.1016\/j.bmcl.2025.130265_bb0065","doi-asserted-by":"crossref","first-page":"40974","DOI":"10.1039\/C8RA08162J","article-title":"Synthesis and anti-glioblastoma effects of artemisinin-Isothiocyanate derivatives","volume":"8","author":"Nyein","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2025.130265_bb0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/01635581.2019.1648694","article-title":"Multi-targeting by \u03b2-Elemene and its anticancer properties: a good choice for oncotherapy and Radiochemotherapy sensitization","volume":"72","author":"Tong","year":"2020","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bmcl.2025.130265_bb0075","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3892\/or.2012.2022","article-title":"\u0392-Elemene induces glioma cell apoptosis by downregulating Survivin and its interaction with hepatitis B X-interacting protein","volume":"28","author":"Zhang","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmcl.2025.130265_bb0080","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1021\/acs.jmedchem.8b00241","article-title":"Natural product Micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia","volume":"61","author":"Li","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130265_bb0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41419-019-1986-2","article-title":"ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K\/AKT pathway in glioma","volume":"10","author":"Xi","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmcl.2025.130265_bb0090","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.2021.39.15_suppl.2044","article-title":"A phase I dose-escalation study to evaluate pharmacokinetics, safety and tolerability of ACT001 in patients with advanced glioma","volume":"39","author":"Shi","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2025.130265_bb0095","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1021\/acs.jmedchem.9b01328","article-title":"Identification of Parthenolide dimers as activators of pyruvate kinase M2 in xenografts of glioblastoma Multiforme in vivo","volume":"63","author":"Ding","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130265_bb0100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.7150\/jca.38624","article-title":"Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p\/PI3K\/AKT and ERK\/NF-\u03baB signaling pathways","volume":"11","author":"Ning","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.bmcl.2025.130265_bb0105","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200933RR","article-title":"Curcumol alleviates liver fibrosis through inducing autophagy and Ferroptosis in hepatic stellate cells","volume":"36","author":"Zheng","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.bmcl.2025.130265_bb0110","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/D2FO02387C","article-title":"Curcumol inhibits breast Cancer growth via NCL\/ER\u03b136 and the PI3K\/AKT pathway","volume":"14","author":"Wei","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.bmcl.2025.130265_bb0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1142\/S0192415X23500350","article-title":"Curcumol exerts antitumor effect via inhibiting EGFR-Akt-mcl-1 signaling","volume":"51","author":"Li","year":"2023","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.bmcl.2025.130265_bb0120","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.7150\/ijbs.34716","article-title":"Curcumol: from plant roots to Cancer roots","volume":"15","author":"Wei","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.bmcl.2025.130265_bb0125","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.6023\/cjoc202202006","article-title":"Aminofluorination-based structural modification of Curcumol for the construction of 3D-shaped natural product fragment library","volume":"42","author":"Li","year":"2022","journal-title":"Chin J Org Chem"},{"key":"10.1016\/j.bmcl.2025.130265_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/acs.jmedchem.4c01786","article-title":"Discovery of N-Trifluoromethylated Noscapines as novel and potent agents for the treatment of glioblastoma","volume":"68","author":"Cui","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130265_bb0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/acsmedchemlett.3c00462","article-title":"Structural modification of noscapine via Photoredox\/nickel dual catalysis for the discovery of S-phase arresting agents","volume":"15","author":"Li","year":"2024","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130265_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130265_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2017.08.025","article-title":"Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"143","author":"Xu","year":"2018","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:08Z","timestamp":1778570528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"alternative-id":["S0960894X2500174X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130265","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-GBM activities of amide-modified Curcumol derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130265"}}